Company Launches Mobile App for Hemophilia Patients
Reprint from Pfizer World November 13, 2012
Pfizer's new HemMobile app
Specialty Care Business Unit’s Rare Diseases division recently launched HemMobile, a disease-management mobile phone application for hemophilia patients and caregivers.
HemMobile is designed to help people living with hemophilia to record and track their infusions and bleeds, regardless of hemophilia type or what medication is used. The app allows both patients and caregivers to share detailed reports of bleed and infusion log history with their health care professional.
Users can create unique profiles to track treatment information and caregivers can manage the information of multiple hemophilia patients under their care.
For added convenience, HemMobile features a unique optical character recognition scanning technology that allows users to capture the lot number and international unit amount of Pfizer factor products using the camera on their mobile device.
“Business Technology is supporting Pfizer’s marketing leaders in designing and developing reusable cutting-edge digital and mobile capabilities geared toward delivering value to our customers and patients,” said Jeff Keisling, Senior Vice President and Chief Information Officer.
A recent article in FierceMobile Healthcare noted that, “There are more than 40,000 mobile health applications available across multiple platforms and an increasing number are designed to help consumers identify chronic conditions, track symptoms and better manage their diseases. With the growing number of people living with chronic disease, the market for mobile health apps to help patients manage such diseases is large and growing.”
The app was launched at the National Hemophilia Foundation Annual Meeting in Orlando.